These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36130512)

  • 1. Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression.
    Sugitani N; Vendetti FP; Cipriano AJ; Pandya P; Deppas JJ; Moiseeva TN; Schamus-Haynes S; Wang Y; Palmer D; Osmanbeyoglu HU; Bostwick A; Snyder NW; Gong YN; Aird KM; Delgoffe GM; Beumer JH; Bakkenist CJ
    Cell Rep; 2022 Sep; 40(12):111371. PubMed ID: 36130512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade.
    Wu X; Kang X; Zhang X; Xie W; Su Y; Liu X; Guo L; Guo E; Li F; Hu D; Qin X; Fu Y; Peng W; Jia J; Wang C
    Cancer Sci; 2021 Nov; 112(11):4444-4456. PubMed ID: 34382294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyuridine-rich cytoplasmic DNA antagonizes STING-dependent innate immune responses and sensitizes resistant tumors to anti-PD-L1 therapy.
    Pandya P; Vendetti FP; El-Ghoubaira J; Pathak S; Deppas JJ; Jones R; Columbus AV; Zhang Y; Ivanov D; Huang Z; MacDonald KM; Harding SM; Buj R; Aird KM; Beumer JH; Sobol RW; Bakkenist CJ
    bioRxiv; 2024 Apr; ():. PubMed ID: 38883769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of [
    Carlucci G; Carney B; Sadique A; Vansteene A; Tang J; Reiner T
    Nucl Med Biol; 2017 May; 48():9-15. PubMed ID: 28157626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate Cancer.
    Tang Z; Pilié PG; Geng C; Manyam GC; Yang G; Park S; Wang D; Peng S; Wu C; Peng G; Yap TA; Corn PG; Broom BM; Thompson TC
    Clin Cancer Res; 2021 Sep; 27(17):4898-4909. PubMed ID: 34168048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Cyclin C or CDK8 provides ATR inhibitor resistance by suppressing transcription-associated replication stress.
    Lloyd RL; Urban V; Muñoz-Martínez F; Ayestaran I; Thomas JC; de Renty C; O'Connor MJ; Forment JV; Galanty Y; Jackson SP
    Nucleic Acids Res; 2021 Sep; 49(15):8665-8683. PubMed ID: 34329458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells.
    Abt ER; Le TM; Dann AM; Capri JR; Poddar S; Lok V; Li L; Liang K; Creech AL; Rashid K; Kim W; Wu N; Cui J; Cho A; Lee HR; Rosser EW; Link JM; Czernin J; Wu TT; Damoiseaux R; Dawson DW; Donahue TR; Radu CG
    Cell Rep; 2022 Jan; 38(2):110236. PubMed ID: 35021095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation.
    Vendetti FP; Karukonda P; Clump DA; Teo T; Lalonde R; Nugent K; Ballew M; Kiesel BF; Beumer JH; Sarkar SN; Conrads TP; O'Connor MJ; Ferris RL; Tran PT; Delgoffe GM; Bakkenist CJ
    J Clin Invest; 2018 Aug; 128(9):3926-3940. PubMed ID: 29952768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
    Odhiambo DA; Pittman AN; Rickard AG; Castillo RJ; Bassil AM; Chen J; Ravotti ML; Xu ES; Himes JE; Daniel AR; Watts TL; Williams NT; Luo L; Kirsch DG; Mowery YM
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1315-1327. PubMed ID: 38104870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simian virus 40 large T antigen induces IFN-stimulated genes through ATR kinase.
    Forero A; Giacobbi NS; McCormick KD; Gjoerup OV; Bakkenist CJ; Pipas JM; Sarkar SN
    J Immunol; 2014 Jun; 192(12):5933-42. PubMed ID: 24799566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress.
    Kemp MG; Sancar A
    J Biol Chem; 2016 Apr; 291(17):9330-42. PubMed ID: 26940878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.
    Vendetti FP; Lau A; Schamus S; Conrads TP; O'Connor MJ; Bakkenist CJ
    Oncotarget; 2015 Dec; 6(42):44289-305. PubMed ID: 26517239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1.
    Moiseeva T; Hood B; Schamus S; O'Connor MJ; Conrads TP; Bakkenist CJ
    Nat Commun; 2017 Nov; 8(1):1392. PubMed ID: 29123096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy.
    Vendetti FP; Pandya P; Clump DA; Schamus-Haynes S; Tavakoli M; diMayorca M; Islam NM; Chang J; Delgoffe GM; Beumer JH; Bakkenist CJ
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionally-instructed modifiers of response to ATR inhibition in experimental glioma.
    Walter B; Hirsch S; Kuhlburger L; Stahl A; Schnabel L; Wisser S; Haeusser LA; Tsiami F; Plöger S; Aghaallaei N; Dick AM; Skokowa J; Schmees C; Templin M; Schenke-Layland K; Tatagiba M; Nahnsen S; Merk DJ; Tabatabai G
    J Exp Clin Cancer Res; 2024 Mar; 43(1):77. PubMed ID: 38475864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage-induced ATM- and Rad-3-related (ATR) kinase activation in non-replicating cells is regulated by the XPB subunit of transcription factor IIH (TFIIH).
    Kemp MG
    J Biol Chem; 2017 Jul; 292(30):12424-12435. PubMed ID: 28592488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase.
    Buisson R; Boisvert JL; Benes CH; Zou L
    Mol Cell; 2015 Sep; 59(6):1011-24. PubMed ID: 26365377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature mitotic entry induced by ATR inhibition potentiates olaparib inhibition-mediated genomic instability, inflammatory signaling, and cytotoxicity in BRCA2-deficient cancer cells.
    Schoonen PM; Kok YP; Wierenga E; Bakker B; Foijer F; Spierings DCJ; van Vugt MATM
    Mol Oncol; 2019 Nov; 13(11):2422-2440. PubMed ID: 31529615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
    Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latex of Euphorbia antiquorum-induced S-phase arrest via active ATM kinase and MAPK pathways in human cervical cancer HeLa cells.
    Hsieh WT; Lin HY; Chen JH; Lin WC; Kuo YH; Wood WG; Lu HF; Chung JG
    Environ Toxicol; 2015 Sep; 30(10):1205-15. PubMed ID: 24706497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.